Iran joins elite ADC-producing countries with Tederox and Padynex, cutting costs by over 90 percent, expanding HER2-positive cancer treatment access, and showcasing rapid biopharmaceutical advancement despite sanctions.

Iran ranks fourth globally in high-impact research on advanced aircraft engines, including hypersonic propulsion, reflecting a focused, sanctions-resistant scientific strategy that has positioned it ahead of several traditional aerospace powers.

Iran Cancer Institute in Tehran has become West Asia’s largest cancer hospital, combining advanced treatment, research, education, and cutting-edge technologies while significantly expanding Iran’s regional and global standing in comprehensive cancer care and medical innovation.

Iran’s domestically developed ProSPECT II cardiac SPECT scanner has positioned it among a select group of countries capable of manufacturing advanced nuclear imaging systems, offering world-class diagnostic performance, lower costs, rapid servicing, and proven clinical reliability.

Iran's Jikan IAT-40, the world's first commercial ice adhesion tester, accurately measures ice shear stress for developing icephobic coatings and has been exported to European research institutions.

Iran test-fired the Sayyad-3G naval missile, debuting vertical launch capability, 150-kilometer range, Mach 7 speed, and networked air defense integration to strengthen fleet protection in the Strait of Hormuz.

Iran indigenizes gas separation membrane technology, ending import dependence, cutting flaring emissions, saving foreign exchange, and positioning itself among energy technology leaders.